Fluicell AB (publ) (STO:FLUI)
Sweden · Delayed Price · Currency is SEK 27.30
+1.10 (4.20%)
Nov 3, 2026, 5:25 PM CET
Fluicell AB Market Cap
Fluicell AB has a market cap or net worth of 37.5 million as of November 3, 2026. It is the 45,886th most valuable company in the world and the 701st biggest in Sweden. Its market cap has increased by 108.40% in one year.
Market Cap
37.50M
Enterprise Value
39.47M
Revenue
18.44M
Global Rank
Country Rank
#701 Sweden
PE Ratio
13.42
ChartMarket Cap Chart
Since April 18, 2018, Fluicell AB's market cap has decreased from 113.77M to 37.50M, a decrease of -67.04%. That is a compound annual growth rate of -12.17%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 3, 2026 | 37.50M | 173.00% |
| Dec 30, 2025 | 13.74M | -30.31% |
| Dec 30, 2024 | 19.71M | 14.60% |
| Dec 29, 2023 | 17.20M | -54.87% |
| Dec 30, 2022 | 38.12M | -85.77% |
| Dec 30, 2021 | 267.82M | 14.56% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Apr 18, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Biovica International AB | 99.25M |
| OncoZenge AB | 82.94M |
| Ascelia Pharma AB | 71.84M |
| Pila Pharma AB | 70.12M |
| AcouSort AB | 69.63M |
| Annexin Pharmaceuticals AB | 54.58M |
| Nanologica AB | 52.60M |
| NextCell Pharma AB | 36.21M |